Accencio® is a technology company founded in 2017, headquartered in the United States. The company's slogan, "See IP differently™," encapsulates its core mission of driving innovation at the intersection of molecular science and intellectual property (IP). Accencio® offers cloud-based, subscription products that provide fully visualized, data-rich interactive landscapes to accelerate and enhance drug discovery and commercialization. Their innovative approach to "See IP Differently™" empowers users to be more innovative and supports biopharma researchers in their pursuit of breakthrough discoveries.
The company operates in the Analytics and Information Technology industries, positioning itself at the forefront of technology and scientific advancement.
Accencio® recently received a Convertible Note investment on 28 July 2022 from J. Hunt Holdings, suggesting a continued interest from investors in the company's vision and potential for growth.